Fusion Harboring Mast Cells Can Explain Molecular Positivity in Flow Cytometric MRD Negative Core Binding Factor AML

Jacqueline A. Cook,Loren Lott, Jenna Perry, Arun Nalla,Dongbin Xu,Chad A. Hudson,Denise A. Wells,Michael R. Loken,Andrew J. Menssen

Blood（2024）

引用 0|浏览14

暂无评分

摘要

Molecular measurable residual disease (MRD) can persist in core binding factor acute myeloid leukemia (AML) in otherwise disease-free patients. Utilizing cell sorting followed by fluorescent in situ hybridization, we show that detection is due to mast cells.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要